Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-19

Clinical Trial Update: Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease [NA]

View source ↗

Summary

Completed clinical trial evaluating differential effects of ergocalciferol (vitamin D2) versus cholecalciferol (vitamin D3) therapies in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)
  • ergocalciferol (ergocalciferol)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Chronic Kidney Disease | NA | Status: COMPLETED